Literature DB >> 16730826

The stepping test and its learning process in different degrees of unilateral striatal lesions by 6-hydroxydopamine in rats.

Xin Fang1, Kenji Sugiyama, Soichi Akamine, Hiroki Namba.   

Abstract

Four different levels of the nigrostriatal dopamine system lesions were produced by injections of 6-hydroxydopamine at one-, two-, three-, or four-sites in the striatum and drug-induced rotational movement and stepping test were performed to evaluate behavioral impairments in the rat model of Parkinson's disease. A dose-dependent progressive loss of tyrosine hydroxylase-positive cells in the substance nigra pars compacta was observed in rats with striatal lesion from one- to four-sites. Though the differences in the rotational behavior and stepping test between the lesioned and control rats were highly significant, there were no differences in those behaviors among four groups of lesioned rats. During observation of these behavioral tests, the authors found that the times of trials required for acquisition of the stepping test on the first day of training, which reflected learning acuity, increased in a dose-dependent manner in the lesioned rats as compared with the controls. On the contrary, the times of trials on the next day and in the next week, which reflected retention of the acquired memories, were not different among the groups. In conclusion, the rotational movement and stepping test were not sensitive enough to distinguish severity of the striatal lesions, and learning acuity, but not retention of memories, was disturbed by the striatal lesions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16730826     DOI: 10.1016/j.neures.2006.04.010

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  5 in total

Review 1.  Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease.

Authors:  Yunqi Xu; Junqiang Yan; Peng Zhou; Jiejie Li; Huimin Gao; Ying Xia; Qing Wang
Journal:  Prog Neurobiol       Date:  2012-02-25       Impact factor: 11.685

Review 2.  Peripheral stimulation in treating Parkinson's disease: Is it a realistic idea or a romantic whimsicality?

Authors:  Tetsuya Asakawa; Huan Fang; Zhen Hong; Kenji Sugiyama; Takao Nozaki; Hiroki Namba
Journal:  Intractable Rare Dis Res       Date:  2012-11

3.  Novel surface modified polymer-lipid hybrid nanoparticles as intranasal carriers for ropinirole hydrochloride: in vitro, ex vivo and in vivo pharmacodynamic evaluation.

Authors:  Chandrakantsing V Pardeshi; Veena S Belgamwar; Avinash R Tekade; Sanjay J Surana
Journal:  J Mater Sci Mater Med       Date:  2013-06-01       Impact factor: 3.896

4.  Neuroprotective effect of neuroserpin in non-tPA-induced intracerebral hemorrhage mouse models.

Authors:  Wei Li; Tetsuya Asakawa; Sha Han; Baoguo Xiao; Hiroki Namba; Chuanzhen Lu; Qiang Dong; Liang Wang
Journal:  BMC Neurol       Date:  2017-11-07       Impact factor: 2.474

5.  Repeated Intrastriatal Botulinum Neurotoxin-A Injection in Hemiparkinsonian Rats Increased the Beneficial Effect on Rotational Behavior.

Authors:  Alexander Hawlitschka; Carsten Holzmann; Andreas Wree; Veronica Antipova
Journal:  Toxins (Basel)       Date:  2018-09-11       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.